🚨Impact of Repeal on Minority Biomedical Research Support Program
Terminating National Institutes of Health Minority Biomedical Research Support Program and Rescinding the Program's Related Regulation
Summary
The Department of Health and Human Services (HHS), in consultation with the National Institutes of Health (NIH), is repealing the regulation relating to the Minority Biomedical Research Support (MBRS) program in compliance with Executive Order (E.O.) 14173 (Ending Illegal Discrimination and Restoring Merit-Based Opportunity) and E.O. 14151 (Ending Radical and Wasteful Government DEI Programs and Preferencing), and to abide by Supreme Court precedent. HHS remains committed to ensuring equal treatment under the law throughout its grant programs.
Agencies
- Health and Human Services Department
Business Impact
$$$ - High
The repeal of the Minority Biomedical Research Support (MBRS) program indicates significant changes in funding priorities and regulatory compliance related to federal grants, affecting those eligible for biomedical research funding. Businesses seeking federal funding may face new eligibility requirements without emphasis on racial classifications.